009420.KS
009420.KS
KR7009420001
HANALL BIOPHARMA
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
2.24T EUR
3.13T EUR
2.97T EUR
2.22T EUR
Enterprise Value
2.25T EUR
3.14T EUR
2.98T EUR
2.23T EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
--
--
--
--
Price to Sales
13.76x
19.23x
18.68x
18.66x
Price to Book
--
19.35x
18.3x
13.74x
EV/Revenue
13.85x
19.32x
18.73x
18.72x
EV/EBITDA
309.35x
--
730.56x
968.42x
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-0.18%
-0.69%
-0.48%
-0.61%
ende